Navigation Links
KV Pharmaceutical Company Completes Financial Restatement with the Filing of Fiscal 2007 Form 10-K
Date:3/25/2008

cal and technology factors, which among others, could cause actual results or events to differ materially from those set forth or implied by the forward-looking statements and related assumptions.

Such factors include (but are not limited to) the following: (1) changes in the current and future business environment, including interest rates and capital and consumer spending; (2) the difficulty of predicting FDA approvals, including timing, and that any period of exclusivity may not be realized; (3) acceptance and demand for new pharmaceutical products; (4) the impact of competitive products and pricing, including as a result of so-called authorized-generic drugs; (5) new product development and launch, including the possibility that any product launch may be delayed or that product acceptance may be less than anticipated; (6) reliance on key strategic alliances; (7) the availability of raw materials and/or products manufactured for the Company under contract manufacturing arrangements with third parties; (8) the regulatory environment, including regulatory agency and judicial actions and changes in applicable law or regulations; (9) fluctuations in revenues; (10) the difficulty of predicting international regulatory approval, including timing; (11) the difficulty of predicting the pattern of inventory movements by the Company's customers; (12) the impact of competitive response to the Company's sales, marketing and strategic efforts; (13) risks that the Company may not ultimately prevail in litigation; (14) the completion of the Company's financial statements for the first, second and third quarters of fiscal 2008; (15) actions by the Securities and Exchange Commission and the Internal Revenue Service with respect to the Company's stock option grants and accounting practices; (16) the risks detailed from time to time in the Company's filings with the Securities and Exchange Commission; and (17) the impact of credit market disruptions on the fair value of auct
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. AUDIO from Medialink and Solvay Pharmaceuticals: Men with Type 2 Diabetes at Increased Risk for Low Testosterone Should Talk to Their Doctors
2. MAP Pharmaceuticals Appoints H. Ward Wolff to Board of Directors
3. Sales and Marketing Effectiveness in Pharmaceutical Companies Increases Brand Performance
4. Conatus Pharmaceuticals Appoints Anthony W. Fox, MD, Ph.D., as Chief Medical Officer
5. XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007
6. Dreier LLP Announces Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated (VRTX)
7. Alseres Pharmaceuticals, Inc. Raises $5 Million
8. Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals
9. Transcept Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
10. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated
11. Sagent Pharmaceuticals Launches Ciprofloxacin Injection, USP, 5% Dextrose Premix Bag
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 2015 There are times when doing ... But in their latest article , Clean Crawls ... make when doing their own crawl space repairs and ... mistake homeowners make is to add additional vents to ... crawl space. The article states that, “Unfortunately, studies have ...
(Date:3/31/2015)... March 31, 2015 Miraca Life Sciences, ... and expanded its breast pathology offering , to ... , Miraca Life Sciences’ breast pathology services feature:, ... Consensus-based approach to terminology and diagnostic criteria ... Heredity breast cancer panels , Molecular ...
(Date:3/31/2015)... March 31, 2015 First Choice ... emergency rooms in the United States, announced that it ... , “I am pleased to announce that we are ... in Haslet,” said Dr. James M. Muzzarelli, Executive Medical ... Choice Emergency Room is revolutionizing the delivery of emergency ...
(Date:3/31/2015)... March 31, 2015 The Buffalo ... peers across the country for distinguished service to its ... New York State Athletic Trainers’ Association (NYSATA) is proud ... these NYS athletic trainers - especially during March as ... Ed Block Courage Award for NFL Athletic Training ...
(Date:3/30/2015)... Minneapolis, MN (PRWEB) March 31, 2015 ... established to aid patients and family members who may ... Ondansetron, during pregnancy for morning sickness. The site was ... the conviction of GlaxoSmithKline in C.A. No. 11-10398-RWZ, filed ... The Toronto Star reports that this case ...
Breaking Medicine News(10 mins):Health News:Top 7 Crawl Space Mistakes Made by DIY Homeowners are Listed in New Article from Clean Crawls 2Health News:Top 7 Crawl Space Mistakes Made by DIY Homeowners are Listed in New Article from Clean Crawls 3Health News:Miraca Life Sciences Formalizes and Expands Breast Pathology Business 2Health News:Miraca Life Sciences Formalizes and Expands Breast Pathology Business 3Health News:First Choice Emergency Room to Open New Facility in Haslet, Texas 2Health News:NYS Athletic Trainers' Association Congratulates Buffalo Bills Athletic Training Staff for National Award 2Health News:NYS Athletic Trainers' Association Congratulates Buffalo Bills Athletic Training Staff for National Award 3Health News:Robert Gardner Law Announces Resource Site for Patients Prescribed Zofran During Pregnancy 2
... BIRMINGHAM, Ala., March 24 BioHorizons announces today ... Thursday, April 30, to Saturday, May 2, at ... on recent advances in digital dentistry, treatment planning, ... restorations.Scientific sessions will bring together the outstanding and ...
... March 24 Perrigo Company (Nasdaq: PRGO ... approval from the U.S. Food and Drug Administration to ... has been determined to be therapeutically equivalent (AB) to ... for the topical treatment of acne. Klaron(R) Lotion had ...
... stress the importance of genetic testing and diagnosis , , ... heart disorder called Danon disease progresses rapidly and is ... study. , The recently recognized disease is a type ... mutations in the lysosome-associated membrane protein gene (LAMP2). Until ...
... included doctor training, patient education and feedback, , , TUESDAY, ... be a better approach to helping people battle chronic ... including more than 400 U.S. veterans, researchers found that ... that included education for patients in pain and their ...
... Tissue Culture Cells ,Infection with human ... transcriptase (hTERT) gene in both normal human cells ... has been suspected of causing or promoting cancer, ... has been unclear. Several other cancer-related viruses stimulate ...
... University of Maryland,s Maryland Performance Excellence ... Mikulski and Benjamin Cardin, today announce the winners ... role-model organizations that successfully implement systematic processes for ... are evaluated rigorously by an independent board of ...
Cached Medicine News:Health News:BioHorizons Announces Its 2009 Global Symposium: Bringing Together Top Thought Leaders in the Dental Implant Industry to Provide Insight on Integrating Technology into the Continuum of Care 2Health News:Perrigo Announces FDA Approval for Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion) 2Health News:Danon Disease Can Be Quickly Fatal, Study Finds 2Health News:Collaborative Care Helps Ease Chronic Pain 2Health News:Collaborative Care Helps Ease Chronic Pain 3Health News:Also in the March 24 JNCI 2Health News:Also in the March 24 JNCI 3Health News:Also in the March 24 JNCI 4Health News:Also in the March 24 JNCI 5Health News:Also in the March 24 JNCI 6Health News:Maryland Performance Excellence Awards Program Announces Winners of Maryland Quality Awards 2Health News:Maryland Performance Excellence Awards Program Announces Winners of Maryland Quality Awards 3Health News:Maryland Performance Excellence Awards Program Announces Winners of Maryland Quality Awards 4
(Date:3/30/2015)... 2015  Cochlear Corporation Vice President of U.S. ... to join Valencia Technologies ( www.valenciatechnologies.com ) and ... , who is the CEO of Valencia.  Schloffman ... will be responsible for generating enthusiasm and support ... coin-sized neuromodulation device in the treatment of ...
(Date:3/30/2015)... 30, 2015   MultiVir Inc. ("MultiVir"), a ... product candidates for the treatment of multiple oncological indications, ... statement on Form S-1 with the U.S. Securities and ... offering of shares of its common stock. The number ... for the proposed offering have not yet been determined. ...
(Date:3/30/2015)... , March 30, 2015   GlassesUSA , the online ... of $12.5 million in new financing led by Viola ... funding will further GlassesUSA,s aggressive business growth and accelerate their ... of online eyewear, both B2C and B2B. GlassesUSA ... COO Eldad Rothman , and CTO Roy Yamner ...
Breaking Medicine Technology:Cochlear VP of U.S. Sales Jerry Schloffman Accepts Chief of Market Development Position at Valencia Technologies 2MultiVir Files Registration Statement for Proposed Initial Public Offering 2GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3
... Systems, Inc. (Nasdaq: DCTH ) today announced ... its 505(b)(2) New Drug Application (NDA) for its proprietary ... (FDA). The Company had previously submitted Module 4, consisting ... late April 2010. The Company is seeking an indication ...
... 2010 Regenicin, Inc. (OTC Bulletin Board: RGIN ... cell therapies to restore the health of damaged tissues and ... 11-13, 2011 in San Francisco. Randall McCoy, CEO of Regenicin, ... bringing new regenerative medicine products to market. ...
Cached Medicine Technology:Delcath Completes New Drug Application Submission to the FDA for the Chemosaturation Delivery System 2Delcath Completes New Drug Application Submission to the FDA for the Chemosaturation Delivery System 3Regenicin CEO to Present at OneMedForum Business Development and Finance Conference 2
Supplied sterile in peel-open packages. Intended for one-time use....
... Used for catheter positioning and exchange in ... the wire guide coils allows utilization of ... smooth transition to a very flexible tip. ... is the most rigid coiled wire guide ...
... catheter positioning and exchange ... inner diameter of wire ... of an extra heavy ... tip flexibility. Supplied sterile ...
Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: